Read all the latest and past featured news about the leading cardiac diabetic medicine company - Cardiac Lifecare. Our team works closely to keep you updated on the newest developments.
Third-party manufacturing has become an essential part of the pharma industry, especially for cardiac and diabetic medicines. It allows businesses to maintain consistent quality, reduce production costs, and scale their operations without investing in manufacturing infrastructure.
Read More
Setting up a Revised Schedule M plant in Baddi is essential for pharma companies aiming for GMP compliance in 2026. This guide explains plant setup requirements, compliance checklist, investment cost, and export advantages under updated Indian regulations.
Read More
Learn practical strategies to expand your cardiac diabetic PCD franchise, increase monopoly coverage, diversify products, and grow your pharma distribution network successfully.
Read More
Compare cardiac diabetic PCD franchise vs general pharma franchise to understand demand, competition, and long-term profit potential in the specialized pharma business segment.
Read More
Understand the drug license, GST registration and documents required to start a cardiac diabetic PCD franchise in India. This guide explains legal requirements, compliance steps and important approvals needed to build a legally secure cardiac diabetic pharma business.
Read More
The cardiac diabetic pharma franchise offers strong and stable profit margins due to rising demand for chronic disease medicines in India. With recurring prescriptions and low competition, this segment ensures consistent monthly income.
Read More
Build a comprehensive list of cardiac and diabetic pharma products, including top cardiac medicines and diabetic drug combinations, in India. Boost your pharma product portfolio to drive better franchise growth and long-term profits.
Read More
Latest insights on the cardiac diabetic pharma market in India, including growth trends, medicine demand, industry developments, and chronic care business opportunities.
Read More